MCV vaccination in the presence of vaccine-associated Guillain–Barré Syndrome risk: A decision analysis approach

Abstract The study evaluates the benefits of meningococcal conjugate vaccine (MCV4) vaccination against the burden of vaccine-associated Guillain–Barré Syndrome (GBS) using simulation. An 11-year-old cohort was followed over an 8-year period in a simulation model Table 3 Figs. 1 and 2 to estimate he...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2010-01, Vol.28 (3), p.817-822
Hauptverfasser:	Cho, Bo-Hyun, Clark, Thomas A, Messonnier, Nancy E, Ortega-Sanchez, Ismael R, Weintraub, Eric, Messonnier, Mark L
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Allergy and Immunology Amputation Applied microbiology Biological and medical sciences Child Cohort Studies Decision analysis Decision making Decision Support Techniques Disability Disease Female Fundamental and applied biological sciences. Psychology Guillain-Barre Syndrome - chemically induced Guillain–Barré Syndrome Hearing loss Humans Male Meningitis Meningococcal disease Meningococcal Infections - prevention & control Meningococcal Vaccines - adverse effects Meningococcal Vaccines - immunology Microbiology Neisseria meningitidis Population Quality-adjusted life years Surveillance Treatment Outcome Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Vaccines, Conjugate - adverse effects Vaccines, Conjugate - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!